Objectives. Our study objective was to determine whether the presence of steal'prone anatomy conferred an increased risk in the development of intraoperative myocardial ischemia.
33 (53%) it was ~90% stenosed. The incidence of ischemia (transesophageal echocardiography or intraoperative electrocar· diography, or both) was similar in patients with and without steal'prone coronary anatomy (18 [29%] of 62 patients vs. 39
[31 %] of 124 patients, p = 0.87,95% confidence interval = -0.13 to 0.17). The incidence of intraoperative ischemia was simHar in patients who received isoflurane or sufentanil anesthesia (20 [32%] of 62 patients vs. 37 [30%] of 124 patients, p = 0.87). The incidence of tachycardia and hypotension was low (increases in heart rate = 9.8%, and decreases in systolic blood pressure = 10 .8% of total monitoring time during the prebypass period compared with preoperative baseline values). The incidence of adverse cardiac outcome was similar in patients with and without preoperative steal· prone coronary anatomy (4 [ Conclusions. These findings demonstrate that under strict hemodynamic control the presence of steal'prone anatomy does not confer an increased risk in the development of intraoperative myocardial ischemia.
(J Am Coli CardioI1992; 20:1205-12) coronary artery steal and myocardial ischemia. Isoflurane is a coronary vasodilator in both animals and humans (8) (9) (10) (11) (12) , and it can cause redistribution of myocardial blood flow (intercoronary and transmural steal) in specific animal models (10, 11) . Ischemic changes (regional mechanical dysfunction and redistribution of myocardial blood flow) have been demonstrated in canine preparations (11,13) and an association between isoflurane and markers of myocardial ischemia (electrocardiographic [ECG] and metabolic changes) has been observed in at-risk patients undergoing surgery (8, (14) (15) (16) .
Patients with "steal-prone anatomy" (total occlusion of one coronary artery that is supplied distally by collateral vessels from another coronary artery with a 2:50% stenosis) may be particularly at risk for the development of intraoperative myocardial ischemia when an anesthetic agent with vasodilator properties is being administered (17) . Because >400,000 cardiac surgical procedures are performed annually in the United States and 7 million of 25 million noncardiac surgical procedures are performed in patients who have or are at risk for coronary artery disease (18) , knowledge of the coronary anatomy may be an important part of preoperative risk assessment. Additionally, if the presence of steal-prone anatomy does confer an increased risk for myocardial ischemia, then the use of certain anesthetic agents with vasodilator properties may be contraindicated. Thus, restricting the use of an anesthetic agent such as isoflurane in these patients would involve a substantial change in current anesthetic practice.
Although the safety of isoflurane has been suggested in patients undergoing surgery (19) (20) (21) (22) the deleterious effects of isoflurane may be evident only in high risk patients with steal-prone anatomy (17) . Thus, our study objective was to evaluate the risk of myocardial ischemia in patients with and without steal-prone anatomy under isoflurane anesthesia (vs. a high dose narcotic technique using sufentanil). Coronary anatomy was assessed by preoperative coronary angiography and myocardial ischemia was measured by continuous intraoperative electrocardiography and transesophageal echocardiography.
Methods
Study group. After institutional approval and informed consent were obtained, 186 patients (185 men and I woman, 37 to 79 years of age [mean ±SD 62 ± 9]) scheduled for elective coronary artery bypass graft surgery at the San Francisco Veterans Administration Medical Center between August 1987 and March 1990 were randomized to receive isoflurane or sufentanil anesthesia. The demographic and clinical data collected for each patient included a history of prior myocardial infarction, previous coronary artery bypass graft surgery or angioplasty, hypertension, diabetes mellitus, unstable angina and preoperative cardiac medications. Preoperative ejection fraction was determined by ventriculography, and the number of significant coronary artery stenoses noted. Significant stenosis was defined as a ;::70% diameter stenosis of the left anterior descending, left circumflex or right coronary artery and a ;::50% diameter stenosis of the left main coronary artery.
Coronary angiography. Coronary angiography was performed with the Seldinger percutaneous technique. Ventriculography was performed in the 30° right anterior oblique and 60° left anterior oblique projections. All patients' angiograms were analyzed for evidence of steal-prone anatomy, defined as total occlusion in one coronary artery that is supplied distally by collateral flow from another coronary artery with a >50% stenosis (17) . Each study was reviewed by an investigator unaware of the research information obtained from the echocardiographic and specialized ECG monitoring. Stenoses were graded subjectively by visual assessment of the cineangiograms. Total occlusions were identified in the right coronary artery, and in the anterior descending and proximal circumflex branches of the left coronary artery. Next, angiographic evidence of collateral blood supply to the zone or zones beyond each total obstruction was identified. Finally, the number of angiograms in which the artery supplying the collateral vessels having a ;::50% (diameter reduction) stenosis was determined. JACC Vol. 20, No.5 November I, 1992 :1205 Management of anesthesia. Measurements of heart rate and systolic blood pressure were obtained during the 48-h preoperative period while the patients were receiving maximal medical therapy. The baseline values of heart rate and systolic blood pressure were determined by averaging the last five preoperative values obtained for each variable. Routine clinical monitors included seven-lead electrocardiography and radial artery and pulmonary artery catheters. The end-tidal isoflurane concentration was continuously monitored by mass spectrometry and the data were stored in a microcomputer. No clinician providing direct patient care had access to the research information obtained from the echocardiographic and specialized ECG monitoring.
Patients received diazepam and morphine sulfate as preanesthetic medication, and all cardiac medications were continued until the time of operation. Patients were randomized to receive either isoflurane or high dose sufentanil anesthesia by a random number-generated method. Sixtytwo patients received isoflurane and 124 patients received sufentanil. The number of patients in the two anesthetic groups was unequal because of a larger protocol in which these patients were involved. All patients received 100% inspired oxygen to maintain arterial partial pressure of oxygen (Pao 2 ) >70 mm Hg, and ventilation was controlled to maintain arterial partial pressure of carbon dioxide (Paco 2 ) between 35 and 45 mm Hg.
The anesthesiologists were requested to maintain heart rate within ±20% and systolic blood pressure within ±20% of preoperative baseline values throughout the study (prebypass) period. If the anesthesiologist judged that anesthetic depth was inadequate, inspired isoflurane concentration was increased; in those who received sufentanil, additional sufentanil was given. Any hemodynamic aberrations occurring in either group after increases in anesthetic depth were treated with vasodilators and beta-adrenergic blocking agents, as needed. The administration of all cardiovascular medications was recorded.
Transesophageal echocardiography. Immediately after tracheal intubation, a gastroscope tipped with either a 3.5-MHz (Diasonics Inc.) or a 5-MHz phased-array transducer (General Electric Co.) was introduced into the esophagus. The transducer was positioned and maintained at the level of the mid-papillary muscles to obtain a short-axis view of the left ventricle. Transesophageal echocardiographic data were recorded continuously onto videotape during the prebypass period (that is, from completion of tracheal intubation to the onset of cardiopulmonary bypass).
The real-time videotape was edited to obtain samples for analysis. Echocardiographic samples of 6O-s duration were obtained every 15 min throughout the prebypass period. AdditionaIly, samples were obtained at other pre-specified times to detect whether anesthetic or surgicaIly imposed stresses had any immediate effect on regional wall motion. During the prebypass period, samples were obtained immediately after tracheal intubation and at 4 min before, and I and 6 min after each of the following surgical events: skin incision, sternotomy, pericardiotomy and aortic and right atrial cannulation.
The short-axis, cross-sectional image was divided into four segments by using the papillary muscles as guides (23, 24) . This floating reference system compensated for translational and rotational movements of the heart. A segment was considered suitable for wall motion analysis if 70% of its entire endocardial outline was visible continuously throughout systole and diastole. All samples were visually analyzed by two investigators by consensus; these investigators had no knowledge of patient identity, clinical outcome or time of sampling. The wall motion of each of the four segments was graded as follows: 0 = normal, 1 = mild hypokinesia, 2 = severe hypokinesia with myocardial thickening, 3 = akinesia, and 4 = dyskinesia. Myocardial thickening was estimated by visual inspection in real time and slow motion. Each patient's best pre bypass wall motion score was used as his or her baseline score. A transesophageal echocardiographic episode suggestive of ischemia was defined by regional wall motion worsening =::2 grades and lasting =:: 1 min. The interobserver variability for definition of a transesophageal echocardiographic ischemic episode was 3% and intraobserver variability was 2% (for both observers).
Electrocardiography. Electrocardiographic monitoring was performed by using a two-channel AM Holter ECG recorder (Marquette Electronics, series 8500) for 2 days preoperatively (baseline) and also from the time of induction of anesthesia to the onset of cardiopulmonary bypass. The frequency response met the American Heart Association specification for ST changes, the cutoff limit being 0.05 Hz for low frequency and 80 Hz for high frequency. Two bipolar leads, CC s and modified CMs, were used. Each complete ECG recording on Holter tape was scanned visually using an ECG analysis system (Marquette series 8000). All abnormal QRS complexes (for example, ventricular ectopic beats and conduction abnormalities) were excluded. A continuous two-lead ST segment trend was then generated for the entire tape. The baseline ST segment level was defined as the average ST segment during a stable period (usually 1 h) preceding each episode. All possible ischemic episodes were reviewed and verified by two investigators who had no knowledge of patient identity and outcome. An ECG ischemic episode was defined as reversible ST depression =::0.1 mV from baseline at J + 60 ms, or >0.2 mV ST elevation at the J point lasting for at least 1 min. During tachycardia when J + 60 ms fell within the T wave, the time after the J point was shortened to a minimum of J + 40 ms.
The characteristics of each ECG ischemic episode including the magnitude (ST segment), episode duration, severity (area under the ST time-curve), as well as the ischemic burden (min of ischemialh monitored) also were determined.
Hemodynamics. Intraoperatively, systolic and diastolic blood pressures were continuously measured with the use of radial artery catheters in all 186 patients. Heart rates were LEUNG ET AL. 1207 STEAL-PRONE ANATOMY AND MYOCARDIAL ISCHEMIA derived from the ECG tracings. Pulmonary artery systolic and diastolic pressures were continuously measured in 183 patients (3 patients did not have interpretable tracings). The zero reference point was located 5 cm posterior to the sternal angle in a direction perpendicular to the frontal plane of the chest. Systolic, diastolic, mean arterial and pulmonary artery pressures and heart rate were measured continuously on entry into the operating room and the data stored in a microcomputer (Toshiba Tlooo, Toshiba Corporation) with the use of a digital interface system. All hemodynamic data also were recorded continuously onto hard copy at 1 mmls with a four-channel strip chart recorder (Marquette, 4-Inch Direct Digital Writer) linked to the hemodynamic monitor (Marquette 7010, frequency response 0.05 to 120 Hz). Hemodynamic data were averaged every 60 s and entered into the microcomputer. The time clocks on transesophageal echocardiography, the Holter monitor and hemodynamic recorder were synchronized before induction of anesthesia.
The hemodynamic data were analyzed as follows: 1) heart rate, systolic blood pressure, diastolic blood pressure and pulmonary artery diastolic pressure were sampled from the computer every 60 s; 2) data on the hard copy were reviewed to ensure that artifacts (such as erroneous values resulting from blood drawing or flushing of catheters) were excluded from analysis; and 3) the data were entered into a computer spreadsheet (Statview 512+, Brainpower) and the frequency distributions for heart rate and systolic blood pressure were determined for the entire prebypass period for each patient.
We defined significant hemodynamic changes as >20% increases in heart rate, systolic blood pressure or pulmonary diastolic pressure or >20% decreases in systolic or diastolic blood pressure.
Operative technique. Cardiopulmonary bypass was performed using a bubble oxygenator and hemodilution and moderate systemic hypothermia (26° to 28°C). Multidose cold blood (8°C, hematocrit 20% to 25%) with potassium cardioplegia (20 mEqlliter) and topical saline/ice slush were used for myocardial protection during cardiopulmonary bypass. Distal anastomoses were performed during continuous aortic cross-clamping, followed by proximal vein grafting during partial aortic occlusion. One hundred seventy-seven patients received a vein graft and 177 patients received an internal mammary artery graft to either the left anterior descending or the first diagonal coronary artery. The pericardium was left open in all patients.
The quality of the bypass grafts was assessed by surgeons who were unaware of the echocardiographic and hemodynamic findings. The grafts were graded qualitatively as poor, fair, very good and excellent.
Outcome measurements. Both 12-lead electrocardiography and creatine kinase (CK) MB isoenzyme concentrations were obtained preoperatively (control) and daily for the 1st 3 postoperative days. Adverse major outcomes were myocardial infarction, ventricular failure or cardiac death. These were defined as 1) myocardial infarction-new Q waves (=::40 ms, or =::25% of the R wave in lead a VF) on requiring an intraaortic balloon pump; and 3) cardiac deathdeath attributed to cardiac cause during the period of hospitalization. A cardiac cause was defined as either myocardial infarction, arrhythmia or ventricular failure due to a cardiac condition. Statistical methods. Chi-square analysis with continuity correction was applied to categoric data. A Student t test was used to test the difference between the means in the two groups. Nonparametric data were assessed by MannWhitney U test. Differences in heart rate and blood pressure were assessed by one-way analysis of variance with the use of repeated measures. A p value < 0.05 (two-sided) identified significant differences.
Results
Overall, the demographic data and preoperative medications were similar in patients with or without steal·prone anatomy (Table 1) .
Hemodynamics. Intraoperative hemodynamic variables were well controlled. The incidence of tachycardia and hypotension was low (increases in heart rate = 9.8%, and decreases in systolic blood pressure = 10.8% of total monitoring time during the pre bypass period compared with preoperative baseline values) and was not different between patients with and without steal-prone anatomy.
Anatomy. Fifty-five percent of patients (103 of 186) had 100% occlusion of at least one major coronary artery. Twenty-two percent (41 of 186) had 100% occlusion of at least one major artery but had either no collateral vessels or collateral vessels supplied by an ipsilateral vessel or by a vessel <50% stenosed. Sixty-two (33%) of the 186 patients had steal-prone anatomy. Of these 62 patients, 5 (8%) had collateral vessels supplied by a coronary artery that was ;::50% to 69% stenosed, 24 (39%) had collateral vessels supplied by a coronary artery that was ;::70% to 89% stenosed, and 33 (53%) had collateral vessels supplied by a coronary artery that was ;::90% stenosed.
Myocardial ischemia. The incidence of ischemia as assessed by transesophageal echocardiography or intraoperative electrocardiography, or both, was similar in patients with and without steal-prone anatomy (18 [29%] of 62 patients vs. 39 [31%] of 124 patients, p = 0.87, 95% confidence interval -0.13 to 0.17). The incidence of ischemia was similar in patients who received isoflurane or sufentanil anesthesia (20 [32%] of 62 patients vs. 37 [30%] of 124 patients, p = 0.87). In the isoflurane group, 42% (26 of 62) of patients had steal-prone anatomy, with 8 (31%) of these manifesting ischemia on electrocardiography or transesophageal echocardiography, or both. In the sufentanil group, 29% (36 of 124) had steal-prone anatomy, with 10 (28%) developing ischemia (p = 0.98 vs. isoflurane group).
The characteristics of transesophageal echocardiographic and of ECG episodes did not differ significantly between the patients with or without steal-prone anatomy ( Table 2) .
The distribution of transesophageal echocardiographic ischemic episodes at the level of the short axis is shown in Figure 1 . Intraoperative transesophageal echocardiographic ischemic episodes occurred frequently in the area at risk determined by preoperative coronary angiography. Ninetyone percent of the new intraoperative prebypass regional wall motion abnormalities occurred in regions supplied by a critically stenosed (>70%) coronary artery. Forty-four percent of the transesophageal echocardiographic ischemic episodes occurred in the myocardium supplied by the right coronary artery, 36.6% occurred in regions supplied by the left anterior descending artery and 19.5% in regions supplied by the left circumflex artery.
Other factors. The concentration of isoflurane did not appear to influence the risk of developing intraoperative myocardial ischemia. The mean end-tidal isoflurane concentration was similar in patients who did and did not develop Values are expressed as percent or as mean value ± 1 SD. AUC = area under the curve, a measure that provides an estimate of the severity of an electrocardiographic ischemic episode; WMS = wall motion score. The wall motion· of each of the four segments of the left ventricle at the level of the short axis was graded according to a 5-point scale (see text). A transesophageal echocardiographic episode suggestive of ischemia was defined by regional wall motion ~2 grades and lasting ~ 1 min.
transesophageal echocardiographic ischemia (0.90% vs. 0.88%, p = 0.89). In fact, transesophageal echocardiographic ischemic episodes occurred at both low (0.47%) and high (1.75%) concentrations of isoflurane.
The intraoperative drug data are summarized in Table 3 . Patients who had steal-prone coronary anatomy were given significantly more ephedrine and neosynephrine to maintain Patients who were randomized to receive isoflurane anesthesia also received significantly more ephedrine and neosynephrine to control blood pressure than those randomized to receive sufentanil anesthesia. However, in the 1 st 24 h postoperatively, neither the incidences or the dose ranges of the vasoactive agents used in the two groups were different. The number of grafts, total aortic crossclamp time and cardiopulmonary bypass time and the surgeon's overall assessment of the grafts were similar in patients receiving isoflurane or sufentanil ( Table 4 ). The incidence of adverse cardiac outcome also was similar in patients regardless of their preoperative coronary anatomy. Five (8%) of the 62 patients with steal-prone anatomy had an adverse cardiac outcome, compared with 14 (11%) of the 124 patients without steal-prone anatomy (p = 0.67). (45) 12 (21) I (2) 3 (5) 1 (2) I (2) (26) 2 (2) 8 (6) 3 (2) 3 (2) 14 (t I) Data are expressed as mean value:!: I SD or number (%) of patients in each subgroup.
Discussion
Our study demonstrated that under strict hemodynamic control, the presence of steal-prone anatomy does not increase the risk of developing intraoperative myocardial ischemia. These data also suggest that in patients with steal-prone coronary anatomy, the use of an anesthetic agent such as isoflurane, which posses;es vasodilator properties, does not appear to confer additional risk.
Comparison with previous studies. A review of coronary angiograms in 16,249 patients who participated in the Coronary Artery Surgery Study (CASS) demonstrated that 23% of the patients had steal-prone coronary anatomy (17) . It has been suggested that studies examining clinical evidence of adverse effects from coronary steal must be done in the subsets of patients with coronary artery disease with stealprone anatomy.
Does the presence of steal-prone coronary anatomy increase the risk of intraoperative myocardial ischemia? In a randomized trial of the use of one of four anesthetic. agents for coronary artery bypass graft surgery, Slogoff et al. (25) suggested that the incidence of ECG ischemia did not differ between patients with and without steal-prone anatomy. However, their study was limited by a lack of hemodynamic control, as reflected by a rather high incidence of hemodynamic aberrations (86% of their patients had a systolic blood pressure> 180 or <90 mm Hg or a heart rate >90 beats/min). Because hemodynamic aberrations such as tachycardia or hypotension may independently precipitate myocardial isch-. emia, Slogoff et al. (25) cannot assess the direct effect of preoperative coronary anatomy. In our study, when we rigorously controlled hemodynamic variables, the incidence lACC Vol. 20, No.5 November I, 1992 :1205 of transesophageal echocardiographic or ECG ischemia was similar regardless of the preoperative coronary anatomy. The low incidence of heart rate and blood pressure abnormalities in our study allows a direct determination of the role of steal-prone anatomy in influencing the risk of myocardial ischemia development without the confounding effects of hemodynamic changes.
Reasons for lack of increased risk for myocardial ischemia in present patients with steal-prone anatomy. The conditions previously described for vasodilator-induced coronary steal include 1) an arteriolar-type dilator like dipyridamole, and 2) stenoses of the arteries supplying collateral flow to the ischemic region (26) . Isoflurane has been demonstrated to dilate predominantly coronary arterioles in the canine model (9) and thus potentially has properties similar to those of dipyridamole. The vasodilator effect of isoflurane on small resistance vessels would therefore be ,capable of causing maldistribution of coronary blood flow. By definition, our patients with steal-prone anatomy had stenoses of arteries supplying collateral flow to an ischemic region. In fact, 53% of the patients with steal-prone anatomy had a collateralsupplying vessel that was =::90% stenosed.
Role of isoflurane. Why, then, did we not observe an increased incidence of myocardial ischemia with isoflurane in patients with steal-prone anatomy? Several possible explanations exist. First, isoflurane is only a mild coronary vasodilator (12) . Although one MAC (minimal alveolar concentration) of isoflurane produced an increase in coronary blood flow, this increase was extremely small (26%) compared with the 400% increase in absolute coronary blood flow induced by the potent coronary vasodilator adenosine in awake dogs (12) . If isoflurane is a weak coronary vasodilator, then a much higher concentration (in excess of that used clinically and not tested in this current study) may be necessary to impair coronary autoregulation.
Role of perfusion pressure. Second, conditions in which isoflurane are associated with myocardial ischemia frequently involve significant hypotension (8, 16, 18) . Induction of anesthesia in these studies typically resulted in a 30% to 45% decrease in coronary perfusion pressure. Therefore, it is difficult to distinguish between reductions in coronary perfusion pressure and a redistribution of blood flow within the myocardium as the cause of ischemia in these studies. Two reports demonstrated the importance of perfusion pressure when studying the potential for any agent to cause ischemia in a poststenotic or a collateral flow-dependent myocardium. Cason et al. (27) demonstrated that in a canine preparation, coronary steal did not occur in the collateralsupplied myocardium when coronary perfusion pressure was kept constant by aortic constriction. Conzen et al. (28) similarly found that isoflurane induced hypotension and decreased blood flow and tissue oxygen pressures of collateral flow-dependent myocardial areas in dogs. However, neither isoflurane nor dipyridamole caused such alterations when arterial pressure was normal.
Role of ephedrine and neosynephrine. Third, patients with steal-prone anatomy received significantly more neosynephrine or ephedrine, or both, to maintain blood pressure in our study. Such agents with alpha-agonist properties may be protective for the myocardium at risk. In a canine model, Feigl et al. (29) increased sympathetic activity by intracoronary infusion of norepinephrine in the presence of a 70% area reduction stenosis of the left main coronary artery. They observed nearly uniform transmural adrenergic coronary vasoconstriction even during coronary underperfusion. The persistence of alpha-receptor mediated coronary vasoconstriction during coronary underperfusion was thought to have an anti transmural steal action during myocardial ischemia. These investigators hypothesized that alpha-receptormediated coronary vasoconstriction in the outer layers of the left ventricle retards the subepicardial steal of flow from inner to outer layers that occurs during ischemia. Hence, it is conceivable that the increased use of neosynephrine in our patients with steal-prone anatomy may have a beneficial effect in reducing the incidence of ischemia. Similarly, because patients randomized to receive isoflurane also received more ephedrine and neosynephrine to control blood pressure than did those randomized to receive sufentanil anesthetic, these agents may have mitigated the vasodilator effect of isoflurane.
Clinical implications. Our study demonstrated that the incidence of intraoperative myocardial ischemia was similar in patients with or without steal-prone anatomy. Furthermore, the choice of an anesthetic agent with vasodilator properties also did not influence the incidence of myocardial ischemia. Specifically, there is no evidence that isoflurane, an anesthetic agent and a vasodilator, should be restricted in patients with coronary artery disease, including those with steal-prone anatomy if systemic hemodynamic variables are carefully controlled. Additionally, because isoflurane lowers myocardial oxygen consumption (30) , this reduction may have a protective effect on the myocardium at risk, negating the effect of coronary steal. Our results also support the importance of controlling perfusion pressure when studying the potential for any agent to cause myocardial ischemia.
Limitations of the study. Our results do not exclude the potential of isoflurane to induce coronary steal because our study was not designed to investigate this phenomenon. Rather, we studied whether the risk of myocardial ischemia was increased in patients with steal-prone anatomy under isoflurane anesthesia. If the risk of myocardial ischemia and adverse cardiac outcomes was not increased under isoflurane anesthesia, then the presence of coronary steal induced by isoflurane under these conditions is clinically unimportant.
We did not prospectively randomize patients into receiving isoflurane or sufentanil anesthesia according to their presence or absence of steal-prone anatomy. However, the preoperative demographic factors as well as the intraoperative surgical characteristics were not different between patients with and without steal-prone anatomy. Whether our STEAL-PRONE ANATOMY AND MYOCARDIAL ISCHEMIA results hold in higher risk patients (those with poorer ventricular function, prior aortocoronary bypass surgery or angioplasty) remain to be proved.
Additionally, we did not investigate whether higher concentrations of isoflurane induce myocardial ischemia. Our study design was to investigate whether isoflurane used as a primary anesthetic agent (in standard clinical concentrations) increased the risk of myocardial ischemia. Our study does not exclude the possibility that isoflurane used as the sole agent may increase the incidence of myocardial ischemia in patients with or without steal-prone anatomy.
Finally, angiographically visible collateral channels represent only a fraction of collateral circuitry. With angiography, we can only visualize channels> 100 JIm in diameter, giving no insight regarding the microcirculation (31) . There is also evidence from contrast echocardiography that collateral channels not visualized on angiography were evident from contrast injection (32) . Furthermore, this epicardial arcade of vessels may not reflect the presence of intramyocardial collateral circulation. In fact, the development of angiographic collateral channels has been shown to be a very dynamic occurrence (33) . Therefore, the term "steal-prone anatomy" is an oversimplification of the coronary anatomy.
Summary. In summary, our study demonstrated that under strict hemodynamic control, i.e., when heart rate and blood pressure are controlled within narrow limits, the presence of steal-prone anatomy does not increase the incidence of intraoperative myocardial ischemia or adverse cardiac outcome. Additionally, the choice of an anesthetic agent with vasodilator properties, such as isoflurane, does not appear to confer additional risk in patients with steal-prone anatomy under conditions of strict hemodynamic control.
